This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Legend Biotech Ireland Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sujuan Wang: Innovator in Cancer Treatment
Introduction
Sujuan Wang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of cancer treatment through his innovative work on chimeric antigen receptors.
Latest Patents
Wang holds a patent for "Anti-DLL3 chimeric antigen receptors and uses thereof." This patent provides insights into anti-DLL3 chimeric antigen receptors (CARs) and DLL3 binding proteins. These innovations are particularly relevant for the treatment of DLL3 associated disorders, such as small cell lung cancer.
Career Highlights
Sujuan Wang is currently employed at Legend Biotech Ireland Limited. His work focuses on developing advanced therapies that target specific cancer markers, enhancing treatment efficacy for patients.
Collaborations
Wang collaborates with talented individuals in his field, including Tao Zhao and Yuanyuan Peng, who contribute to the research and development of innovative cancer therapies.
Conclusion
Sujuan Wang's contributions to cancer treatment through his patented innovations highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile